269 related articles for article (PubMed ID: 37752151)
21. Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020.
Sermet-Gaudelus I; Temmam S; Huon C; Behillil S; Gajdos V; Bigot T; Lurier T; Chrétien D; Backovic M; Delaunay-Moisan A; Donati F; Albert M; Foucaud E; Mesplées B; Benoist G; Faye A; Duval-Arnould M; Cretolle C; Charbit M; Aubart M; Auriau J; Lorrot M; Kariyawasam D; Fertitta L; Orliaguet G; Pigneur B; Bader-Meunier B; Briand C; Enouf V; Toubiana J; Guilleminot T; van der Werf S; Leruez-Ville M; Eloit M
Euro Surveill; 2021 Apr; 26(13):. PubMed ID: 33797390
[TBL] [Abstract][Full Text] [Related]
22. Human seasonal coronavirus neutralization and COVID-19 severity.
Wells DA; Cantoni D; Mayora-Neto M; Genova CD; Sampson A; Ferrari M; Carnell G; Nadesalingam A; Smith P; Chan A; Raddi G; Castillo-Olivares J; Baxendale H; Temperton N; Heeney JL
J Med Virol; 2022 Oct; 94(10):4820-4829. PubMed ID: 35705514
[TBL] [Abstract][Full Text] [Related]
23. Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the hologic panther fusion.
Cordes AK; Rehrauer WM; Accola MA; Wölk B; Hilfrich B; Heim A
J Med Virol; 2021 Jul; 93(7):4438-4445. PubMed ID: 33350484
[TBL] [Abstract][Full Text] [Related]
24. Interactions between seasonal human coronaviruses and implications for the SARS-CoV-2 pandemic: A retrospective study in Stockholm, Sweden, 2009-2020.
Dyrdak R; Hodcroft EB; Wahlund M; Neher RA; Albert J
J Clin Virol; 2021 Mar; 136():104754. PubMed ID: 33601153
[TBL] [Abstract][Full Text] [Related]
25. Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses.
Otter CJ; Fausto A; Tan LH; Khosla AS; Cohen NA; Weiss SR
Proc Natl Acad Sci U S A; 2023 Apr; 120(15):e2218083120. PubMed ID: 37023127
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia.
Lynch SA; Subbarao K; Mahanty S; Barber BE; Roulis EV; van der Hoek L; McCarthy JS; Spann KM
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452482
[TBL] [Abstract][Full Text] [Related]
27. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.
Hoffmann HH; Sánchez-Rivera FJ; Schneider WM; Luna JM; Soto-Feliciano YM; Ashbrook AW; Le Pen J; Leal AA; Ricardo-Lax I; Michailidis E; Hao Y; Stenzel AF; Peace A; Zuber J; Allis CD; Lowe SW; MacDonald MR; Poirier JT; Rice CM
Cell Host Microbe; 2021 Feb; 29(2):267-280.e5. PubMed ID: 33357464
[TBL] [Abstract][Full Text] [Related]
28. Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters.
Field CJ; Heinly TA; Patel DR; Sim DG; Luley E; Gupta SL; Vanderford TH; Wrammert J; Sutton TC
Emerg Microbes Infect; 2022 Dec; 11(1):1103-1114. PubMed ID: 35333692
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms.
Cantoni D; Siracusano G; Mayora-Neto M; Pastori C; Fantoni T; Lytras S; Di Genova C; Hughes J; On Behalf Of The Ambulatorio Medico San Luca Villanuova Group ; Lopalco L; Temperton N
Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679903
[TBL] [Abstract][Full Text] [Related]
30. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
Petrie JG; Bazzi LA; McDermott AB; Follmann D; Esposito D; Hatcher C; Mateja A; Narpala SR; O'Connell SE; Martin ET; Monto AS
J Infect Dis; 2021 Jul; 224(1):49-59. PubMed ID: 33755731
[TBL] [Abstract][Full Text] [Related]
31. Seroprevalence of four endemic human coronaviruses and, reactivity and neutralization capability against SARS-CoV-2 among children in the Philippines.
Sayama Y; Okamoto M; Saito M; Saito-Obata M; Tamaki R; Joboco CD; Lupisan S; Oshitani H
Sci Rep; 2023 Feb; 13(1):2310. PubMed ID: 36759702
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
33. Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.
Qin S; Xia X; Shi X; Ji X; Ma F; Chen L
Bioinformatics; 2021 Jan; 36(21):5133-5138. PubMed ID: 32805023
[TBL] [Abstract][Full Text] [Related]
34. Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination.
Amanat F; Clark J; Carreño JM; Strohmeier S; Yellin T; Meade PS; Bhavsar D; Muramatsu H; Sun W; Coughlan L; Pardi N; Krammer F
J Virol; 2023 Mar; 97(3):e0166422. PubMed ID: 36779758
[TBL] [Abstract][Full Text] [Related]
35. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T-cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2.
Becerra-Artiles A; Nanaware PP; Muneeruddin K; Weaver GC; Shaffer SA; Calvo-Calle JM; Stern LJ
PLoS Pathog; 2023 Jul; 19(7):e1011032. PubMed ID: 37498934
[TBL] [Abstract][Full Text] [Related]
36. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.
Schneider WM; Luna JM; Hoffmann HH; Sánchez-Rivera FJ; Leal AA; Ashbrook AW; Le Pen J; Ricardo-Lax I; Michailidis E; Peace A; Stenzel AF; Lowe SW; MacDonald MR; Rice CM; Poirier JT
Cell; 2021 Jan; 184(1):120-132.e14. PubMed ID: 33382968
[TBL] [Abstract][Full Text] [Related]
37. Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity.
Guzmán-Martínez O; Guardado K; Varela-Cardoso M; Trujillo-Rivera A; Gómez-Ñañez I; Ortiz-León MC; Espinosa R; Ramos C; Pérez-Carreón JI; López-Guerrero DV; Sampieri CL; Alanís-García AB; Rojas-Durán F; Zenteno-Cuevas R; Gutiérrez M; Montero H
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501647
[TBL] [Abstract][Full Text] [Related]
38. Early protective effect of a ("pan") coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration.
Abdelaziz MO; Raftery MJ; Weihs J; Bielawski O; Edel R; Köppke J; Vladimirova D; Adler JM; Firsching T; Voß A; Gruber AD; Hummel LV; Fernandez Munoz I; Müller-Marquardt F; Willimsky G; Elleboudy NS; Trimpert J; Schönrich G
Front Immunol; 2023; 14():1166765. PubMed ID: 37520530
[TBL] [Abstract][Full Text] [Related]
39. Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins.
Shi Y; Shi J; Sun L; Tan Y; Wang G; Guo F; Hu G; Fu Y; Fu ZF; Xiao S; Peng G
J Virol; 2021 Mar; 95(7):. PubMed ID: 33414160
[TBL] [Abstract][Full Text] [Related]
40. Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses.
Wratil PR; Schmacke NA; Karakoc B; Dulovic A; Junker D; Becker M; Rothbauer U; Osterman A; Spaeth PM; Ruhle A; Gapp M; Schneider S; Muenchhoff M; Hellmuth JC; Scherer C; Mayerle J; Reincke M; Behr J; Kääb S; Zwissler B; von Bergwelt-Baildon M; Eberle J; Kaderali L; Schneiderhan-Marra N; Hornung V; Keppler OT
Cell Rep; 2021 Dec; 37(13):110169. PubMed ID: 34932974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
